Institutional Ownership Ptc Therapeutics, Inc. (PTCT)
This table provides information about the institutional ownership of Ptc Therapeutics, Inc. (PTCT). We have compiled data on the 325 institutions that hold shares in the stock, with a total of 83.2 Million shares, which have been reported (via 13F filing form) to have a value of $6.26 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
773,178
shares
|
$58.2 Million
0.01% of portfolio
|
Q3 2025
Added 46.6%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
737,569
shares
|
$55.5 Million
0.01% of portfolio
|
Q3 2025
Reduced 0.22%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
721,202
shares
|
$54.3 Million
0.01% of portfolio
|
Q3 2025
Reduced 25.56%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
702,758
shares
|
$52.9 Million
0.01% of portfolio
|
Q3 2025
Reduced 0.7%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
686,450
shares
|
$51.7 Million
0.03% of portfolio
|
Q2 2023
Added 34.72%
|
|
|
Pacer Advisors, Inc.
Malvern, PA |
Oct 15, 2025 Q3 2025 |
503,966
shares
|
$37.9 Million
0.09% of portfolio
|
Q3 2025
Reduced 31.97%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
490,934
shares
|
$37 Million
0.0% of portfolio
|
Q3 2025
Reduced 18.65%
|
|
|
Rockefeller Capital Management L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
473,758
shares
|
$35.7 Million
0.06% of portfolio
|
Q3 2025
Added 2.31%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
458,330
shares
|
$34.5 Million
0.0% of portfolio
|
Q3 2025
Added 1.04%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
452,209
shares
|
$34.1 Million
0.0% of portfolio
|
Q3 2025
Reduced 21.89%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 14, 2025 Q3 2025 |
438,477
shares
|
$33 Million
4.87% of portfolio
|
Q2 2025
Reduced 0.34%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
430,934
shares
|
$32.4 Million
0.03% of portfolio
|
Q3 2025
Added 27.43%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
424,999
shares
|
$32 Million
0.02% of portfolio
|
Q3 2025
Added 919.38%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
419,417
shares
|
$31.6 Million
0.0% of portfolio
|
Q3 2025
Reduced 63.95%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Nov 13, 2025 Q3 2025 |
378,053
shares
|
$28.5 Million
0.07% of portfolio
|
Q3 2025
Reduced 1.66%
|
|
|
Boston Partners
Boston, MA |
Nov 13, 2025 Q3 2025 |
361,664
shares
|
$27.2 Million
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Panagora Asset Management Inc
Boston, MA |
Nov 13, 2025 Q3 2025 |
348,366
shares
|
$26.2 Million
0.09% of portfolio
|
Q3 2025
Added 21.78%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
331,256
shares
|
$24.9 Million
0.01% of portfolio
|
Q3 2025
Reduced 38.33%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Nov 13, 2025 Q3 2025 |
323,548
shares
|
$24.4 Million
0.01% of portfolio
|
Q3 2025
Added 851.61%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
313,057
shares
|
$23.6 Million
0.0% of portfolio
|
Q3 2025
Added 3.24%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
291,000
shares
|
$21.9 Million
0.03% of portfolio
|
Q3 2025
Reduced 51.97%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 13, 2025 Q3 2025 |
288,767
shares
|
$21.7 Million
0.03% of portfolio
|
Q3 2025
Added 5.29%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Oct 09, 2025 Q3 2025 |
284,891
shares
|
$21.5 Million
0.02% of portfolio
|
Q3 2025
Added 9.37%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2025 Q3 2025 |
280,551
shares
|
$21.1 Million
2.69% of portfolio
|
Q3 2025
New holding
|
|
|
Man Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
265,181
shares
|
$20 Million
0.03% of portfolio
|
Q3 2025
Reduced 60.51%
|
|